{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:33:22Z","timestamp":1776087202473,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873269"],"award-info":[{"award-number":["81873269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873145"],"award-info":[{"award-number":["81873145"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key R&D Program of China","award":["2018YFC1705500"],"award-info":[{"award-number":["2018YFC1705500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Gout is characterized by inflammatory arthritis with hyperuricaemia and deposition of monosodium urate (MSU) crystals in the joints. Several animal models have been proposed based on MSU crystals injection or high-fat diet feeding; however, neither hyperuricaemia model nor acute gout model can effectively reflect clinical features of gout. This study aimed to assess the effectiveness of a compound gout model induced by the combination of MSU crystals injection and high-fat diet feeding.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The compound gout model was induced by high-fat diet feeding per day and the intraplantar injection of MSU crystals (1\u2009mg) into the footpad of each mouse every 10\u2009days. Serum uric acid, foot swelling and pain analyses were performed at days 22, 32 and 42. Gout inflammation, serum proinflammatory cytokines and gut microbiota analyses were performed only at day 42.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Compared to hyperuricaemia model or acute gout model, the compound gout model showed little advantages of elevating serum uric acid, causing foot swelling and gout inflammation, while it caused more severe serum inflammation and gut microbiota dysbiosis. Severe serum inflammation in the compound gout model could be reflected by the increased levels of IL-1\u03b1, IL-4, IL-6, IL-10, IL-12p40, IL-12p70, IFN-\u03b3, KC, MCP-1 and MIP-1\u03b2. In addition, the compound gout model induced more alterations in the gut microbiota, including increasing levels of <jats:italic>Desulfovibrio<\/jats:italic> and <jats:italic>Parasutterella<\/jats:italic>.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The injection of MSU and feed of high-fat diet have a combined effect on elevating serum inflammation and causing gut microbiota disorders in the process of establishing a gout model.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s42358-020-00155-3","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T10:03:06Z","timestamp":1604484186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Combined effects of MSU crystals injection and high fat-diet feeding on the establishment of a gout model in C57BL\/6 mice"],"prefix":"10.1186","volume":"60","author":[{"given":"Xiaoying","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8857-1550","authenticated-orcid":false,"given":"Zhixing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"155_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(10)60665-4","volume":"377","author":"CM Burns","year":"2011","unstructured":"Burns CM, Wortmann RL. Gout therapeutics: new drugs for an old disease. Lancet. 2011;377:165\u201377.","journal-title":"Lancet"},{"key":"155_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMcp1001124","volume":"364","author":"T Neogi","year":"2011","unstructured":"Neogi T. Gout. N Engl J Med. 2011;364:443\u201352.","journal-title":"N Engl J Med"},{"key":"155_CR3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.metabol.2010.07.009","volume":"59","author":"TB VanItallie","year":"2010","unstructured":"VanItallie TB. Gout: epitome of painful arthritis. Metabolism. 2010;59:S32\u20136.","journal-title":"Metabolism"},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11:649.","journal-title":"Nat Rev Rheumatol"},{"key":"155_CR5","first-page":"762820","volume":"2015","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.","journal-title":"Biomed Res Int"},{"key":"155_CR6","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2018.0547","volume":"319","author":"BM Kuehn","year":"2018","unstructured":"Kuehn BM. Chronic disease approaches needed to curb gout\u2019s growing burden. JAMA. 2018;319:1307\u20139.","journal-title":"JAMA"},{"key":"155_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11926-015-0495-2","volume":"17","author":"AM Abeles","year":"2015","unstructured":"Abeles AM. Hyperuricemia, gout, and cardiovascular disease: an update. Curr Rheumatol Rep. 2015;17:13.","journal-title":"Curr Rheumatol Rep"},{"key":"155_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jddst.2017.04.020","volume":"39","author":"S Singh","year":"2017","unstructured":"Singh S, Parashar P, Kanoujia J, Singh I, Saha S, Saraf SA. Technology: transdermal potential and anti-gout efficacy of Febuxostat from niosomal gel. J Drug Deliv Sci Technol. 2017;39:348\u201361.","journal-title":"J Drug Deliv Sci Technol"},{"key":"155_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08982104.2016.1174943","volume":"27","author":"N Singh","year":"2017","unstructured":"Singh N, Parashar P, Tripathi CB, Kanoujia J, Kaithwas G, Saraf SA. Oral delivery of allopurinol niosomes in treatment of gout in animal model. J Liposome Res. 2017;27:130\u20138.","journal-title":"J Liposome Res"},{"key":"155_CR10","doi-asserted-by":"publisher","unstructured":"Parashar P, Mazhar I, Kanoujia J, Yadav A, Kumar P, Saraf SA, Saha S. Biochemistry: appraisal of anti-gout potential of colchicine-loaded chitosan nanoparticle gel in uric acid-induced gout animal model. Arch Physiol Biochem. Epub ahead of print. 2019. \nhttps:\/\/doi.org\/10.1080\/13813455.2019.1702702\n\n.","DOI":"10.1080\/13813455.2019.1702702"},{"key":"155_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/BOR.0b013e328014529a","volume":"19","author":"T Akahoshi","year":"2007","unstructured":"Akahoshi T, Murakami Y, Kitasato H. Recent advances in crystal-induced acute inflammation. Curr Opin Rheumatol. 2007;19:146\u201350.","journal-title":"Curr Opin Rheumatol"},{"key":"155_CR12","doi-asserted-by":"publisher","first-page":"20602","DOI":"10.1038\/srep20602","volume":"6","author":"Z Guo","year":"2016","unstructured":"Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L. Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep. 2016;6:20602.","journal-title":"Sci Rep"},{"key":"155_CR13","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/art.39107","volume":"67","author":"AT Vieira","year":"2015","unstructured":"Vieira AT, Macia L, Galv\u00e3o I, Martins FS, Canesso MCC, Amaral FA, Garcia CC, Maslowski KM, De Leon E, Shim D. Rheumatology: a role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol. 2015;67:1646\u201356.","journal-title":"Arthritis Rheumatol"},{"key":"155_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ijo.2015.244","volume":"40","author":"TL Cranford","year":"2016","unstructured":"Cranford TL, Enos RT, Vel\u00e1zquez KT, McClellan JL, Davis JM, Singh UP, Nagarkatti M, Nagarkatti PS, Robinson CM, Murphy EA. Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB\/N strain. Int J Obes. 2016;40:844\u201351.","journal-title":"Int J Obes"},{"key":"155_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach F, Pogrel J, Chung J, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55\u201363.","journal-title":"J Neurosci Methods"},{"key":"155_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335\u20136.","journal-title":"Nat Methods"},{"key":"155_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-6906-12-S1-P1","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:1\u201318.","journal-title":"Genome Biol"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Thurber RLV, Knight R. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31:814\u201321.","journal-title":"Nat Biotechnol"},{"key":"155_CR19","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","volume":"30","author":"DH Parks","year":"2014","unstructured":"Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30:3123\u20134.","journal-title":"Bioinformatics"},{"key":"155_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0550-4","volume":"17","author":"C Pineda","year":"2015","unstructured":"Pineda C, Fuentes-G\u00f3mez AJ, Hern\u00e1ndez-D\u00edaz C, Zamudio-Cuevas Y, Fern\u00e1ndez-Torres J, L\u00f3pez-Macay A, Alba-S\u00e1nchez I, Camacho-Galindo J, Ventura L, G\u00f3mez-Quir\u00f3z LE. Animal model of acute gout reproduces the inflammatory and ultrasonographic joint changes of human gout. Arthritis Res Ther. 2015;17:1\u20139.","journal-title":"Arthritis Res Ther"},{"key":"155_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13075-018-1550-y","volume":"20","author":"Q Yang","year":"2018","unstructured":"Yang Q, Zhang Q, Qing Y, Zhou L, Mi Q, Zhou J. miR-155 is dispensable in monosodium urate-induced gouty inflammation in mice. Arthritis Res Ther. 2018;20:144.","journal-title":"Arthritis Res Ther"},{"key":"155_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12325-014-0175-z","volume":"32","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv Ther. 2015;32:31\u201341.","journal-title":"Adv Ther"},{"key":"155_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso N, So A. Gout. Mechanisms of inflammation in gout. Arthritis Res Ther. 2010;12:206.","journal-title":"Arthritis Res Ther"},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13:639\u201347.","journal-title":"Nat Rev Rheumatol"},{"key":"155_CR25","doi-asserted-by":"crossref","unstructured":"Cavalcanti N, Marques C, e Lins TL, Pereira M, Rego M, Duarte A, Pitta I, Pitta M. AB0068 cytokine profile in gout: IL-18 and IL-6 are associated with inflammatory activity. Ann Rheum Dis. 2015;74:913.","DOI":"10.1136\/annrheumdis-2015-eular.3201"},{"key":"155_CR26","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ni.3503","volume":"17","author":"NC Di Paolo","year":"2016","unstructured":"Di Paolo NC, Shayakhmetov DM. Interleukin 1\u03b1 and the inflammatory process. Nat Immunol. 2016;17:906\u201313.","journal-title":"Nat Immunol"},{"key":"155_CR27","doi-asserted-by":"publisher","first-page":"8904","DOI":"10.1523\/JNEUROSCI.1146-14.2014","volume":"34","author":"AM Fenn","year":"2014","unstructured":"Fenn AM, Hall JC, Gensel JC, Popovich PG, Godbout JP. IL-4 signaling drives a unique arginase+\/IL-1\u03b2+ microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4R\u03b1 after traumatic spinal cord injury. J Neurosci. 2014;34:8904\u201317.","journal-title":"J Neurosci"},{"key":"155_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1126\/scisignal.aay0574","volume":"13","author":"H Metwally","year":"2020","unstructured":"Metwally H, Tanaka T, Li S, Parajuli G, Kang S, Hanieh H, Hashimoto S, Chalise JP, Gemechu Y, Standley DM. Noncanonical STAT1 phosphorylation expands its transcriptional activity into promoting LPS-induced IL-6 and IL-12p40 production. Sci Signal. 2020;13:624.","journal-title":"Sci Signal"},{"key":"155_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jdermsci.2009.01.003","volume":"54","author":"N Yawalkar","year":"2009","unstructured":"Yawalkar N, Tscharner GG, Hunger RE, Hassan AS. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J Dermatol Sci. 2009;54:99\u2013105.","journal-title":"J Dermatol Sci"},{"key":"155_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ebiom.2018.02.009","volume":"30","author":"F Wang","year":"2018","unstructured":"Wang F, Zhang S, Jeon R, Vuckovic I, Jiang X, Lerman A, Folmes CD, Dzeja PD, Herrmann JJE. Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity. EBioMedicine. 2018;30:303\u201316.","journal-title":"EBioMedicine"},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.pharep.2018.06.001","volume":"70","author":"EA Og\u0142odek","year":"2018","unstructured":"Og\u0142odek EA, Just MJ. The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1\u03b2) and depression with and without posttraumatic stress disorder. Pharmacol Rep. 2018;70:1065\u201372.","journal-title":"Pharmacol Rep"},{"key":"155_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fmicb.2017.00268","volume":"8","author":"T Shao","year":"2017","unstructured":"Shao T, Shao L, Li H, Xie Z, He Z, Wen C. Combined signature of the fecal microbiome and metabolome in patients with gout. Front Microbiol. 2017;8:268.","journal-title":"Front Microbiol"},{"key":"155_CR33","doi-asserted-by":"publisher","first-page":"eaaf9044","DOI":"10.1126\/scitranslmed.aaf9044","volume":"9","author":"TR Chiaro","year":"2017","unstructured":"Chiaro TR, Soto R, Stephens WZ, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med. 2017;9:eaaf9044.","journal-title":"Sci Transl Med"},{"key":"155_CR34","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1111\/1462-2920.14096","volume":"20","author":"L Zhu","year":"2018","unstructured":"Zhu L, Wu Q, Deng C, Zhang M, Zhang C, Chen H, Lu G, Wei F. Adaptive evolution to a high purine and fat diet of carnivorans revealed by gut microbiomes and host genomes. Environ Microbiol. 2018;20:1711\u201322.","journal-title":"Environ Microbiol"},{"key":"155_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1574-6968.2009.01750.x","volume":"299","author":"P Marquet","year":"2009","unstructured":"Marquet P, Duncan SH, Chassard C, Bernalier-Donadille A, Flint HJ. Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett. 2009;299:128\u201334.","journal-title":"FEMS Microbiol Lett"},{"key":"155_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4024\/04SE17A.jbpc.17.02","volume":"17","author":"S Seneff","year":"2017","unstructured":"Seneff S, Causton NJ, Nigh GL, Koenig G, Avalon DJJBPC. Can glyphosates disruption of the gut microbiome and induction of sulfate deficiency explain the epidemic in gout and associated diseases in the industrialized world. J Biol Phys Chem. 2017;17:53\u201376.","journal-title":"J Biol Phys Chem"},{"key":"155_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/annrheumdis-2014-206258","volume":"75","author":"MC Cleophas","year":"2016","unstructured":"Cleophas MC, Cri\u015fan TO, Lemmers H, Toenhake-Dijkstra H, Fossati G, Jansen TL, Dinarello CA, Netea MG, Joosten LA. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann Rheum Dis. 2016;75:593\u2013600.","journal-title":"Ann Rheum Dis"},{"key":"155_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/BOR.0000000000000366","volume":"29","author":"MC Cleophas","year":"2017","unstructured":"Cleophas MC, Cri\u015fan TO, Joosten LA. Factors modulating the inflammatory response in acute gouty arthritis. Curr Opin Rheumatol. 2017;29:163\u201370.","journal-title":"Curr Opin Rheumatol"},{"key":"155_CR39","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1128\/AEM.71.10.5743-5751.2005","volume":"71","author":"A Jim\u00e9nez","year":"2005","unstructured":"Jim\u00e9nez A, Santos MA, Pompejus M, Revuelta JLJA, Microbiology E. Metabolic engineering of the purine pathway for riboflavin production in Ashbya gossypii. Appl Environ Microbiol. 2005;71:5743\u201351.","journal-title":"Appl Environ Microbiol"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-020-00155-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-020-00155-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-020-00155-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T10:11:52Z","timestamp":1604484712000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-020-00155-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1186\/s42358-020-00155-3","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"18 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal handling and experimental procedures were performed in accordance with local ethical committees and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All efforts were made to minimize animal suffering and to reduce the number of animals used. All procedures performed in this study involving animals were approved by the ethics committee of our university.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that there are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}